Evidence map›Paper›PMID 24577790›Full record

ReviewStem cell reviews and reports2014

Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models.

B A Naaijkens, A van Dijk, O Kamp, P A J Krijnen, H W M Niessen, L J M Juffermans

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Stem Cell Therapy against Ischemic Heart Disease.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Frontiers in pharmacology · 2019
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Application of adipose-derived stem cells in heart disease.Journal of cardiovascular translational research · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

B A NaaijkensDepartment of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands, b.naaijkens@erasmusmc.nl.
A van Dijk
O Kamp
P A J Krijnen
H W M Niessen
L J M Juffermans
Amsterdam UMC Location VUmc · NLNetherlands Heart Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of patients survive an acute myocardial infarction (AMI). Their outcome is negatively influenced by post-AMI events, such as loss of viable cardiomyocytes due to a post-AMI inflammatory response, eventually resulting in heart failure and/or death. Recent pre-clinical animal studies indicate that mesenchymal stem cells derived from adipose tissue (ASC) are new promising candidates that may facilitate cardiovascular regeneration in the infarcted myocardium. In this review we have compared all animal studies in which ASC were used as a therapy post-AMI and have focused on aspects that might be important for future successful clinical application of ASC.

Indexed as

Adipose TissueAnimalsCells, CulturedDisease Models, AnimalHumansMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMyocardial Infarction

Identifiers

PMID24577790
OpenAlexW1993353916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.